Raskasionisädehoidoissa

Raskasionisädehoidoissa refers to radiation therapy used during pregnancy. This is a complex and rare medical situation, typically considered only when the benefits of treating the mother's cancer outweigh the potential risks to the fetus. The decision to proceed with radiation therapy during pregnancy involves a multidisciplinary team of oncologists, radiation oncologists, obstetricians, and pediatricians.

The primary concern with radiation therapy during pregnancy is the potential for fetal harm. Radiation can damage developing cells, leading to birth defects, developmental issues, or increased cancer risk in the child later in life. The extent of the risk depends on several factors, including the gestational age of the fetus, the dose of radiation, and the location of the radiation treatment. Early in pregnancy, the fetus is more vulnerable to structural abnormalities, while later in pregnancy, growth restriction and organ dysfunction are greater concerns.

Techniques are employed to minimize radiation exposure to the fetus. This can include precise targeting of the tumor, shielding of the unborn child whenever possible, and careful planning of the treatment field. In some cases, delaying treatment until after delivery might be an option, depending on the type and stage of the cancer and the mother's overall health. If radiation therapy is deemed necessary, close monitoring of both the mother and the fetus throughout the pregnancy is crucial. This involves regular ultrasounds and other diagnostic tests to assess fetal well-being and growth. The long-term health of the child born after maternal radiation exposure is also a subject of ongoing medical observation.